USPTO serial 79352805
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Joseph R. Dages
Joseph R. Dages Gray Ice Higdon, PLLC3939 Shelbyville RoadSuite 201Louisville, KY 40207| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Chemical test reagents for medical purposes; medical diagnostic test strips for blood and saliva analysis; diagnostic testing materials for medical use comprised of medical diagnostic reagents, pads and assays that test for the presence of biologic drugs and biomarkers; diagnostic testing materials for medical use comprised of medical diagnostic reagents and assays for testing body fluids; diagnostic testing materials for medical use comprised of medical diagnostic test strips for blood and saliva analysis; diagnostic preparations and materials, namely, diagnostic preparations for medical purposes; diagnostic substances for medical use; medical preparations for the diagnosis of suboptimal biologic drug levels; medical preparations for the diagnosis of viral infections; diagnostic reagents for medical use; chemical preparations for testing blood for biologic drug levels for medical purposes; chemical preparations for testing blood for antibody levels for medical purposes; pregnancy testing preparations | ACTIVE | — |
| 010 | Medical diagnostic saliva collecting pads; testing apparatus for medical purposes, namely, medical diagnostic apparatus for testing biologic drug levels; testing apparatus for medical purposes, namely, medical diagnostic apparatus for testing antibody levels; testing apparatus for medical purposes, namely, medical diagnostic apparatus for testing viral infections; diagnostic, examination, and monitoring equipment, namely, medical apparatus and instruments for testing and monitoring blood properties, medical diagnostic apparatus for testing biological samples; medical diagnostic apparatus for pregnancy testing; medical diagnostic apparatus for testing for viruses; medical diagnostic saliva collecting vials; blood testing apparatus; diagnostic apparatus for medical purposes for testing biologic drug levels; diagnostic apparatus for medical purposes for testing antibody levels; diagnostic apparatus for medical purposes for testing viral infections; medical instruments for infectious disease testing; tools for medical diagnostics, namely, cytometers for medical diagnostic use, medical instruments and devices for use in therapeutic drug monitoring; medical instruments for use in biomarker quantification | ACTIVE | — |
| 035 | Online retail store services featuring testing apparatus for medical purposes; online retail store services featuring blood testing apparatus; online retail store services featuring chemical test reagents for medical use; retail store services featuring chemical test reagents for medical use; retail store services featuring medical instruments for infectious disease testing; online retail store services featuring diagnostic preparations and materials; online retail store services featuring medical instruments; online retail store services featuring diagnostic reagents for medical use; retail store services featuring diagnostic, examination, and monitoring equipment; retail store services featuring medical preparations; online retail store services featuring diagnostic substances for medical use; retail store services featuring diagnostic preparations and materials; online retail store services featuring medical diagnostic apparatus for testing for viruses; online retail store services featuring tools for medical diagnostics; retail store services featuring blood testing apparatus; online retail store services featuring medical diagnostic test strips; online retail store services featuring medical instruments for infectious disease testing; retail and wholesale store services for pharmaceutical, veterinary and sanitary preparations and medical supplies; online retail store services featuring pregnancy testing preparations; retail store services featuring chemical preparations for testing blood for medical purposes; retail store services featuring tools for medical diagnostics; online retail store services featuring diagnostic apparatus for medical purposes; retail store services featuring medical apparatus; retail store services featuring diagnostic apparatus for medical purposes; retail store services featuring medical diagnostic saliva pads; retail store services featuring diagnostic substances for medical use; retail store services featuring diagnostic apparatus for pregnancy testing; online retail store services featuring medical diagnostic saliva pads; retail store services featuring medical instruments; online retail store services featuring diagnostic apparatus for pregnancy testing; online retail store services featuring diagnostic, examination, and monitoring equipment; retail store services featuring medical diagnostic saliva vials; retail store services featuring diagnostic reagents for medical use; online retail store services featuring medical preparations; retail store services featuring medical diagnostic test strips; retail store services featuring testing apparatus for medical purposes; retail store services featuring diagnostic testing materials for medical use; online retail store services featuring medical diagnostic saliva vials; online retail store services featuring diagnostic testing materials for medical use; online retail store services featuring chemical preparations for testing blood for medical purposes; retail store services featuring medical diagnostic apparatus for testing for viruses; retail store services featuring pregnancy testing preparations | ACTIVE | — |
| 042 | Medical and pharmacological research services; medical laboratory services | ACTIVE | — |
| 044 | Pregnancy testing; medical analysis services for the diagnosis and treatment of persons; medical services; medical testing for diagnostic or treatment purposes; medical information; medical laboratory services for the medical analysis of samples taken from patients for diagnostic and treatment purposes; medical assistance; medical screening; medical diagnostic services, namely, medical diagnosis of suboptimal biologic drug levels; medical diagnostic services, namely, medical diagnosis of viral infections | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 23, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 1, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 1, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 19, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 19, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 19, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 7, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 7, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 7, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 4, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 3, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 3, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 13, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 13, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Sep 13, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 28, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 28, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 28, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 28, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 28, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 18, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 17, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 17, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 15, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 20, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 20, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 15, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 14, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 28, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 25, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 21, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 20, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |